Annual CFF
$119.22 M
-$442.58 M-78.78%
December 31, 2023
Summary
- As of February 7, 2025, BPMC annual cash flow from financing activities is $119.22 million, with the most recent change of -$442.58 million (-78.78%) on December 31, 2023.
- During the last 3 years, BPMC annual CFF has fallen by -$498.53 million (-80.70%).
- BPMC annual CFF is now -80.70% below its all-time high of $617.76 million, reached on December 31, 2020.
Performance
BPMC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$18.38 M
-$159.63 M-89.68%
September 30, 2024
Summary
- As of February 7, 2025, BPMC quarterly cash flow from financing activities is $18.38 million, with the most recent change of -$159.63 million (-89.68%) on September 30, 2024.
- Over the past year, BPMC quarterly CFF has dropped by -$80.02 million (-81.32%).
- BPMC quarterly CFF is now -95.17% below its all-time high of $380.56 million, reached on September 30, 2022.
Performance
BPMC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$278.88 M
-$80.02 M-22.30%
September 30, 2024
Summary
- As of February 7, 2025, BPMC TTM cash flow from financing activities is $278.88 million, with the most recent change of -$80.02 million (-22.30%) on September 30, 2024.
- Over the past year, BPMC TTM CFF has increased by +$172.69 million (+162.63%).
- BPMC TTM CFF is now -57.01% below its all-time high of $648.78 million, reached on March 31, 2020.
Performance
BPMC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BPMC Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -78.8% | -81.3% | +162.6% |
| 3 y3 years | -80.7% | +246.9% | -28.2% |
| 5 y5 years | +2576.8% | +246.9% | -28.2% |
BPMC Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -78.8% | +135.1% | -95.2% | -100.0% | -51.7% | +520.2% |
| 5 y | 5-year | -80.7% | +135.1% | -95.2% | -100.0% | -57.0% | +520.2% |
| alltime | all time | -80.7% | +2576.8% | -95.2% | +2385.7% | -57.0% | >+9999.0% |
Blueprint Medicines Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $18.38 M(-89.7%) | $278.88 M(-22.3%) |
| Jun 2024 | - | $178.01 M(+165.8%) | $358.90 M(+92.8%) |
| Mar 2024 | - | $66.96 M(+331.2%) | $186.19 M(+56.2%) |
| Dec 2023 | $119.22 M(-78.8%) | $15.53 M(-84.2%) | $119.22 M(+12.3%) |
| Sep 2023 | - | $98.40 M(+1757.3%) | $106.19 M(-72.7%) |
| Jun 2023 | - | $5.30 M(>+9900.0%) | $388.35 M(-30.7%) |
| Mar 2023 | - | $0.00(-100.0%) | $560.55 M(-0.2%) |
| Dec 2022 | $561.81 M(+1007.8%) | $2.49 M(-99.3%) | $561.81 M(-2.7%) |
| Sep 2022 | - | $380.56 M(+114.4%) | $577.25 M(+178.0%) |
| Jun 2022 | - | $177.50 M(>+9900.0%) | $207.61 M(+361.7%) |
| Mar 2022 | - | $1.26 M(-92.9%) | $44.97 M(-11.3%) |
| Dec 2021 | $50.72 M(-91.8%) | $17.93 M(+64.2%) | $50.72 M(-79.9%) |
| Sep 2021 | - | $10.92 M(-26.5%) | $252.88 M(-22.5%) |
| Jun 2021 | - | $14.85 M(+111.9%) | $326.30 M(+3.7%) |
| Mar 2021 | - | $7.01 M(-96.8%) | $314.62 M(-49.1%) |
| Dec 2020 | $617.76 M(+81.4%) | $220.09 M(+161.0%) | $617.76 M(+54.6%) |
| Sep 2020 | - | $84.34 M(+2556.4%) | $399.50 M(+25.0%) |
| Jun 2020 | - | $3.17 M(-99.0%) | $319.65 M(-50.7%) |
| Mar 2020 | - | $310.15 M(>+9900.0%) | $648.78 M(+90.5%) |
| Dec 2019 | $340.64 M | $1.83 M(-59.2%) | $340.64 M(+0.3%) |
| Sep 2019 | - | $4.50 M(-98.6%) | $339.57 M(+1.3%) |
| Jun 2019 | - | $332.30 M(>+9900.0%) | $335.19 M(+9749.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $2.01 M(+163.2%) | $3.40 M(-23.6%) |
| Dec 2018 | $4.45 M(-99.2%) | $764.00 K(+576.1%) | $4.45 M(-98.7%) |
| Sep 2018 | - | $113.00 K(-78.1%) | $331.54 M(-0.1%) |
| Jun 2018 | - | $515.00 K(-83.2%) | $331.80 M(-39.4%) |
| Mar 2018 | - | $3.06 M(-99.1%) | $547.43 M(+0.6%) |
| Dec 2017 | $543.95 M(+310.3%) | $327.85 M(>+9900.0%) | $543.95 M(+55.1%) |
| Sep 2017 | - | $372.00 K(-99.8%) | $350.73 M(+0.3%) |
| Jun 2017 | - | $216.14 M(<-9900.0%) | $349.62 M(+163.0%) |
| Mar 2017 | - | -$420.00 K(-100.3%) | $132.96 M(+0.3%) |
| Dec 2016 | $132.58 M(-13.5%) | $134.63 M(<-9900.0%) | $132.58 M(-5633.3%) |
| Sep 2016 | - | -$731.00 K(+41.1%) | -$2.40 M(+9.7%) |
| Jun 2016 | - | -$518.00 K(-35.6%) | -$2.19 M(-101.4%) |
| Mar 2016 | - | -$804.00 K(+134.4%) | $152.97 M(-0.2%) |
| Dec 2015 | $153.22 M(+88.3%) | -$343.00 K(-34.0%) | $153.22 M(-26.4%) |
| Sep 2015 | - | -$520.00 K(-100.3%) | $208.17 M(-0.3%) |
| Jun 2015 | - | $154.63 M(<-9900.0%) | $208.70 M(+273.9%) |
| Mar 2015 | - | -$547.00 K(-101.0%) | $55.82 M(-31.4%) |
| Dec 2014 | $81.35 M(+352.2%) | $54.60 M(>+9900.0%) | $81.35 M(+204.1%) |
| Sep 2014 | - | $17.00 K(-99.0%) | $26.75 M(+0.1%) |
| Jun 2014 | - | $1.75 M(-93.0%) | $26.73 M(+7.0%) |
| Mar 2014 | - | $24.99 M | $24.99 M |
| Dec 2013 | $17.99 M | - | - |
FAQ
- What is Blueprint Medicines annual cash flow from financing activities?
- What is the all time high annual CFF for Blueprint Medicines?
- What is Blueprint Medicines annual CFF year-on-year change?
- What is Blueprint Medicines quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Blueprint Medicines?
- What is Blueprint Medicines quarterly CFF year-on-year change?
- What is Blueprint Medicines TTM cash flow from financing activities?
- What is the all time high TTM CFF for Blueprint Medicines?
- What is Blueprint Medicines TTM CFF year-on-year change?
What is Blueprint Medicines annual cash flow from financing activities?
The current annual CFF of BPMC is $119.22 M
What is the all time high annual CFF for Blueprint Medicines?
Blueprint Medicines all-time high annual cash flow from financing activities is $617.76 M
What is Blueprint Medicines annual CFF year-on-year change?
Over the past year, BPMC annual cash flow from financing activities has changed by -$442.58 M (-78.78%)
What is Blueprint Medicines quarterly cash flow from financing activities?
The current quarterly CFF of BPMC is $18.38 M
What is the all time high quarterly CFF for Blueprint Medicines?
Blueprint Medicines all-time high quarterly cash flow from financing activities is $380.56 M
What is Blueprint Medicines quarterly CFF year-on-year change?
Over the past year, BPMC quarterly cash flow from financing activities has changed by -$80.02 M (-81.32%)
What is Blueprint Medicines TTM cash flow from financing activities?
The current TTM CFF of BPMC is $278.88 M
What is the all time high TTM CFF for Blueprint Medicines?
Blueprint Medicines all-time high TTM cash flow from financing activities is $648.78 M
What is Blueprint Medicines TTM CFF year-on-year change?
Over the past year, BPMC TTM cash flow from financing activities has changed by +$172.69 M (+162.63%)